Combo Therapy for Myelodysplastic Syndromes Misses Survival Goal in Randomized Trial

(MedPage Today) — HOUSTON — Survival in untreated, intermediate- and higher-risk myelodysplastic syndromes (MDS) failed to improve with the addition of the targeted agent venetoclax (Venclexta) to chemotherapy, a large randomized trial showed…

Source link : https://www.medpagetoday.com/meetingcoverage/soho/117342

Author :

Publish date : 2025-09-06 17:16:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

Combo Therapy for Myelodysplastic Syndromes Misses Survival Goal in Randomized Trial

Are You Ready for Measles’ Wrath?

Who Needs a Beta-Blocker After a Heart Attack? RSV Vaccines and Hospitalizations

Related Posts

Which State Plans to End All Vaccine Mandates?

Bisphosphonates Linked With Lower Death Risk After Low-Trauma Break

Immunotherapy Highly Active in Small Study of Advanced CTCL

Who Needs a Beta-Blocker After a Heart Attack? RSV Vaccines and Hospitalizations

Are You Ready for Measles’ Wrath?

For Some, a COVID Vaccine Means Jumping Through Hoops or Hitting the Road

Which State Plans to End All Vaccine Mandates?

Bisphosphonates Linked With Lower Death Risk After Low-Trauma Break

Immunotherapy Highly Active in Small Study of Advanced CTCL

Who Needs a Beta-Blocker After a Heart Attack? RSV Vaccines and Hospitalizations

Combo Therapy for Myelodysplastic Syndromes Misses Survival Goal in Randomized Trial

Are You Ready for Measles’ Wrath?

For Some, a COVID Vaccine Means Jumping Through Hoops or Hitting the Road

Ultra-Processed Foods May Harm Male Fertility, Study Finds

Categories

Archives